Show Summary Details
Page of

Prolotherapy in the USA 

Prolotherapy in the USA
Prolotherapy in the USA

Thomas Dorman

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 March 2021

Scar tissue has a number of mechanical properties which differ from those of normal connective tissue and are considered disadvantageous. It was George Hackett who realized that when ligaments are ‘relaxed’ (his term for ligament insufficiency), hypertrophy of the ligament represented an advantage, contrasting with scar formation which would be a disadvantage. It later transpired that a great deal of benefit could be achieved clinically, in patients with injured ligaments, by the use of a number of proliferant agents. Evidence of the proliferant effect, and a classification of those proliferating solutions that initiate the wound-healing cascade, are outlined in this chapter. The chapter then discusses the treatment by prolotherapy of a number of low back syndromes, all with one underlying phenomenon—that of ligament relaxation and asymlocation in the pelvis. The chapter highlights the potential for prolotherapy as a suitable treatment in other parts of the body, including the neck.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.